您好,欢迎来到易推广 请登录 免费注册

南京亿迅生物科技有限公司 主营产品:ELISA试剂盒,进口ELISA试剂盒,放免试剂盒,实验代测技术服务

易推广认证请放心拨打

13047500758

当前位置:易推广 > 南京亿迅生物科技有限公司>公司新闻>热烈祝贺老师购买我司ELISA试剂盒并成功发表SCI

企业档案

会员类型:会员

已获得易推广信誉   等级评定
41成长值

(0 -40)基础信誉积累,可浏览访问

(41-90)良好信誉积累,可接洽商谈

(91+  )优质信誉积累,可持续信赖

易推广会员:9

工商认证 【已认证】

最后认证时间:

注册号: 【已认证】

法人代表: 【已认证】

企业类型:生产商 【已认证】

注册资金:人民币万 【已认证】

产品数:11018

参观次数:3870331

手机网站:http://m.yituig.com/c112612/

旗舰版地址:http://www.xfswbio.com

公司新闻

热烈祝贺老师购买我司ELISA试剂盒并成功发表SCI

点击次数:491发布时间:2017/4/10

 热烈祝贺老师购买我司elisa试剂盒并成功发表SCI

祝贺我司客户的优质研究成果被知名期刊《Clinical Rheumatology》收录

该论文标题: Predictors of response to TNF-α antagonist therapy in Chinese rheumatoid arthritis
Clinical Rheumatology

发表日期:July 2015, Volume 34

期刊号:Issue 7, pp 1203–1210 




该论文中所使用的IL-34,TNF-a,IL-6,IL-8,MMP-3试剂盒均购自我司。亿迅生物是一家专业的
elisa试剂盒供应商,销售各种进口国产品牌的elisa试剂盒。


 热烈祝贺老师购买我司ELISA试剂盒并成功发表SCI

对于elisa试剂盒,我们提供完善的质量保证,专业的技术解答,耐心周到的售后服务,成为国内多家科研机构和高校的试剂盒指定供应商。

老师在论文后期编辑过程中与我们积极互动,亿迅生物给予了全方位支持,*终顺利被《Clinical Rheumatology》录用。


《Clinical Rheumatology》期刊介绍:
Clinical Rheumatology is an international journal devoted to publishing in the English language original clinical investigation and research in the general field of rheumatology with accent on clinical aspects at postgraduate level. Studies carried out anywhere in the world will be considered the basic criterion for acceptance being the medical and scientific standard of the work described. 


文章介绍
This study aimed to investigate the clinical, immunological, and radiologic predictors of response to tumor necrosis factor (TNF)-α antagonist therapy in Chinese rheumatoid arthritis (RA). Ninety RA patients were divided into two groups according to their responsiveness to TNF-α antagonist therapy at 1 month: group A (responders) and group B (non-responders). After 3 months of therapy, all the 90 patients were re-assessed and re-divided into another two groups: group C (responders) and group D (non-responders). Serum samples and clinical characteristics as well as radiographic features were collected at baseline, first month, and third month post-initial administration of TNF-α antagonist. Serum TNF-α, interleukin (IL)-6, IL-8, IL-34, and matrix metalloproteinase (MMP)-3 were measured by enzyme-linked immunosorbent assay (ELISA). Disease activity and Sharp score were evaluated. (1) Comparisons between groups A and B: subjects in group A showed a lower level of erythrocyte sedimentation rate (ESR) and a higher level of albumin (ALB) at baseline than that of group B (p < 0.05). The cutoff value of ALB for prediction was ≥34.9 g/l and that of ESR was ≤55.5 mm/h. (2) Comparisons between groups C and D: group C showed lower levels of ESR, health assessment questionnaire (HAQ), and IL-34 at baseline (p < 0.05). The threshold for prediction were as follows: ESR ≤60 mm/h, HAQ ≤1.3125, and IL-34 ≤194.12 pg/ml. (3) The serum cytokines were positively correlated with C-reactive protein (CRP) and disease activity index, while ALB was negatively correlated with CRP and disease activity. Baseline ALB ≥34.9 g/l or ESR ≤55.5 mm/h might predict a good response at 1-month treatment of TNF-α antagonist, while baseline ESR ≤60 mm/h, HAQ ≤1.3125, and IL-34 ≤194.12 pg/ml might predict a good response at 3-month treatment.

 

亿迅生物从创立至今,具有多年试剂领域的研发、生产和销售经验,目前已经成长为国内规模较大的试剂研发、生产和销售的综合性企业,一直为科研工作者助力。我们期待您的光临! 

 热烈祝贺老师购买我司ELISA试剂盒并成功发表SCI

 
 

相关产品

中国彩虹热线
在线咨询

提交